Gap shares rise 16% on earnings; Affirm, Quoin Pharma also gain

1 min read | Published on 28 Aug 2026, 05:04 PM |Updated on 28 Aug 2026, 05:47 PM

Reviewed by

Ritika DScanX News Team

Add as a preferred
source on Google

Key Highlights

Gap shares rose 16% to $24.12 on strong Q2 earnings and raised FY26 guidance
Affirm Holdings stock jumped 13% after beating fourth-quarter market expectations
Quoin Pharmaceuticals surged 57% following a $50 million capital raise agreement

*this image is generated using AI for illustrative purposes only.

Gap Inc., Affirm Holdings, and Quoin Pharmaceuticals led market gains on August 28, driven by strong quarterly results and a significant capital raise.

Gap Inc. (NYSE: GAP) saw its stock jump 16% to $24.12 during Friday's pre-market session. The retailer reported better-than-expected second-quarter adjusted earnings per share and raised its full-year 2026 EPS guidance above analyst estimates. Its market capitalization stands at $7.4 billion.

Affirm Holdings (AFRM) shares rose 13% following the release of its fourth-quarter financial results. The fintech company reported performance that exceeded market expectations, triggering a sharp rally in trading.

Quoin Pharmaceuticals (QNRX) recorded the largest move, with shares surging 57%. The company announced a securities purchase agreement with new and existing healthcare-focused institutional investors to raise up to approximately $50 million in gross proceeds.

What the Numbers Show

The market reaction highlights a divergence between operational execution and capital structure events. While Affirm and Gap benefited from operational metrics—specifically earnings beats and guided growth—Quoin’s movement was driven entirely by liquidity injection rather than revenue or profit data. The 57% surge in QNRX suggests investors are pricing in the strategic value of the $50 million capital raise for future pipeline development, despite the absence of disclosed commercial sales figures in this update.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

Will Gap Inc.'s raised 2026 EPS guidance signal a sustained turnaround in the broader apparel sector, or is it an isolated recovery driven by specific brand performance?

How might Affirm's Q4 earnings beat influence regulatory scrutiny on buy-now-pay-later models given the current interest rate environment?

What specific clinical milestones or pipeline assets will Quoin Pharmaceuticals likely prioritize with the newly raised $50 million to justify the 57% stock surge?

Affirm Holdings FY27 Revenue Expected at $5.44B vs $5.29B Est

0 min read | Published on 28 Aug 2026, 02:27 AM |Updated on 28 Aug 2026, 02:27 AM

Reviewed by

Shriram SScanX News Team

Add as a preferred
source on Google

Key Highlights

Affirm Holdings expects FY27 revenue to exceed $5.440 billion, beating the $5.287 billion estimate
Gross merchandise volume (GMV) is projected to be more than $64 billion for the fiscal year
The revenue-to-GMV ratio is seen at 8.5%, indicating platform monetization efficiency

*this image is generated using AI for illustrative purposes only.

Affirm Holdings (NASDAQ: AFRM) expects full-year fiscal 2027 revenue to exceed $5.440 billion, surpassing the consensus estimate of $5.287 billion. The fintech lender also projects gross merchandise volume (GMV) to top $64 billion for the period.

The company indicated that the revenue-to-GMV ratio is seen at 8.5%. This metric reflects the monetization efficiency of the transaction flow processed through its platform.

What the Numbers Show

The projected revenue growth relative to GMV suggests a stable take rate. With revenue expected at $5.440 billion against a GMV floor of $64 billion, the disclosed 8.5% ratio aligns with the upper bound of the guidance, implying consistent pricing power or mix improvement across its merchant network.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the stable 8.5% take rate impact Affirm's competitive positioning against traditional credit card networks and other BNPL providers in a rate-sensitive environment?

What specific strategies is Affirm employing to drive the GMV growth to $64 billion, particularly regarding merchant acquisition in high-volume sectors?

Could the projected revenue exceedance signal an expansion into higher-margin financial products, such as subscription services or international markets?